Richard Payerchin's profile photo

Richard Payerchin

North Olmsted

Editor at Medical Economics. Much to learn. Eager to share. And vice versa. @MedEconomics

Featured in: Favicon medicaleconomics.com Favicon washingtontimes.com Favicon beaconjournal.com Favicon daytondailynews.com Favicon journal-news.com Favicon lmtonline.com Favicon roanoke.com Favicon pressofatlanticcity.com Favicon springfieldnewssun.com Favicon theeagle.com

Articles

  • HHS Secretary Robert F. Kennedy Defends His Policies and "Restructuring" of HHS

    3 weeks ago | infectioncontroltoday.com | Richard Payerchin

    This article first appeared in our sister brand, Medical Economics®. US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr spent yesterday, May 15, 2025, in hearings with the House Appropriations Committee and the Senate Committee on Health, Education, Labor & Pensions (HELP). Physicians in Congress had a chance to inquire of Kennedy on May 14 in the Senate HELP Committee and, earlier in the day, the House Appropriations Committee.

  • FDA, NIH announce food safety collaboration as FDA gives nod to 3 new natural food colorings

    4 weeks ago | foodsafety.einnews.com | Richard Payerchin

    Everzure, a blue food dye extracted from the algae Galdieria sulphuraria, has received approval for use by the U.S. Food and Drug Administration. This image was published on the website of the coloring creator Fermentalg. Meanwhile, FDA and the National Institutes of Health (NIH) will team up on "a new, joint innovative research initiative" devoted to analysis of ultraprocessed foods.

  • The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial Resistance

    Feb 28, 2025 | patientcareonline.com | Richard Payerchin

    This interview appeared originally on partner website Medical Economics. The US may be the global leader in scientific research and medicine, but the nation and its patients are not immune to problems caused by antimicrobial resistance (AMR).

  • Confronting Superbugs: The Critical Battle Against Antimicrobial Resistance

    Feb 25, 2025 | infectioncontroltoday.com | Richard Payerchin

    Our sister brand, Medical Economics, first published this article. The US may be the global leader in scientific research and medicine, but the nation and its patients are not immune to problems caused by antimicrobial resistance (AMR).

  • Drug prices: Introducing research and patient advocacy group AAR

    Feb 11, 2025 | medicaleconomics.com | Richard Payerchin

    A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
29K
DMs Open
No
Richard Payerchin
Richard Payerchin @MJH_JournalRick
13 May 25

RT @IJMSCtweets: "An estimated 70% of individuals with #NMOSD can be classified as poor sleepers.... Decreased #sleep quality was significa…

Richard Payerchin
Richard Payerchin @MJH_JournalRick
9 May 25

If you're interested in learning more about investing in medical devices & technology, here's a great place to start: https://t.co/48nH2KfJbi @MedEconomics #Leaguemed

Richard Payerchin
Richard Payerchin @MJH_JournalRick
8 May 25

RT @PCPCC: In a recent @MedEconomics article, @MJH_JournalRick writes about the opportunity for value-based payment models to "enhance coll…